Corient Private Wealth LLC Purchases Shares of 6,000 Astera Labs, Inc. $ALAB

Corient Private Wealth LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 6,000 shares of the company’s stock, valued at approximately $543,000.

Several other hedge funds have also modified their holdings of ALAB. Oliver Lagore Vanvalin Investment Group acquired a new position in Astera Labs during the second quarter worth approximately $29,000. Bernard Wealth Management Corp. acquired a new position in shares of Astera Labs in the 2nd quarter valued at $36,000. Clearstead Trust LLC grew its stake in shares of Astera Labs by 46,100.0% during the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock valued at $42,000 after buying an additional 461 shares during the period. Advisors Asset Management Inc. increased its holdings in shares of Astera Labs by 68.6% during the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock worth $43,000 after buying an additional 194 shares during the last quarter. Finally, Manchester Capital Management LLC increased its holdings in shares of Astera Labs by 141.5% during the 2nd quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock worth $44,000 after buying an additional 283 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Astera Labs

In other news, General Counsel Philip Mazzara sold 4,620 shares of the company’s stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $668,467.80. Following the sale, the general counsel owned 147,040 shares in the company, valued at approximately $21,275,217.60. This represents a 3.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Jitendra Mohan sold 90,459 shares of the stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the transaction, the chief executive officer directly owned 2,080,418 shares in the company, valued at $301,015,680.42. The trade was a 4.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 586,936 shares of company stock worth $89,331,140 over the last ninety days. Company insiders own 12.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. BNP Paribas Exane assumed coverage on Astera Labs in a research report on Thursday, November 20th. They set an “outperform” rating and a $225.00 price target for the company. Roth Capital boosted their target price on Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Needham & Company LLC raised their price target on shares of Astera Labs from $205.00 to $220.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $188.17.

Astera Labs Stock Down 1.6%

ALAB opened at $167.26 on Monday. The firm’s 50 day moving average is $159.77 and its 200-day moving average is $158.64. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90. The firm has a market capitalization of $28.25 billion, a P/E ratio of 150.68, a P/E/G ratio of 3.12 and a beta of 1.52.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The business had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. During the same period last year, the business earned $0.23 EPS. The business’s revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Equities analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.